[HTML][HTML] Lipoprotein (a)—the crossroads of atherosclerosis, atherothrombosis and inflammation

S Ugovšek, M Šebeštjen - Biomolecules, 2021 - mdpi.com
Increased lipoprotein (a)(Lp (a)) levels are an independent predictor of coronary artery
disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD …

[HTML][HTML] Targeted treatment against lipoprotein (a): the coming breakthrough in lipid lowering therapy

B Sosnowska, S Surma, M Banach - Pharmaceuticals, 2022 - mdpi.com
Atherosclerotic cardiovascular diseases (ASCVD) are a very important cause of premature
death. The most important risk factor for ASCVD is lipid disorders. The incidence of lipid …

Single ascending dose study of a short interfering RNA targeting lipoprotein (a) production in individuals with elevated plasma lipoprotein (a) levels

SE Nissen, K Wolski, C Balog, DI Swerdlow… - Jama, 2022 - jamanetwork.com
Importance Lipoprotein (a)(Lp [a]) is an important risk factor for atherothrombotic
cardiovascular disease and aortic stenosis, for which there are no treatments approved by …

[HTML][HTML] PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

M Banach, P Burchardt, K Chlebus… - Archives of Medical …, 2021 - ncbi.nlm.nih.gov
Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

A comprehensive review on the lipid and pleiotropic effects of pitavastatin

A Sahebkar, N Kiaie, AM Gorabi, MR Mannarino… - Progress in Lipid …, 2021 - Elsevier
Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …

[HTML][HTML] Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation

G Reyes-Soffer, M Westerterp - Pharmacological research, 2021 - Elsevier
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …

[HTML][HTML] A look to the past–what has had the biggest impact on lipids in the last four decades? A personal perspective

M Banach, S Surma - Archives of Medical Science: AMS, 2023 - ncbi.nlm.nih.gov
We live in interesting times, when we finally have the possibility of effective treatment of
patients with lipid disorders, and in fact with numerous effective drugs available, it should be …

Dyslipidemia management in pregnancy: why is it not covered in the guidelines?

J Lewek, M Banach - Current atherosclerosis reports, 2022 - Springer
Abstract Purpose of Review Despite the elevation of lipid values during pregnancy is mostly
physiological, evidence suggest that it may be associated with adverse events. This article …

[HTML][HTML] Risk-factors associated with extremely high cardiovascular risk of mid-and long-term mortality following myocardial infarction: analysis of the Hyperlipidaemia …

K Dyrbuś, M Gąsior, P Desperak, P Trzeciak, J Nowak… - Atherosclerosis, 2021 - Elsevier
Background and aims Risk-factor identification and risk stratification are prerequisites to the
effective primary and secondary prevention of cardiovascular disease (CVD). Patients at the …

[HTML][HTML] The role of polyphenol in modulating associated genes in diabetes-induced vascular disorders

NA Mohd Nor, SB Budin, S Zainalabidin, J Jalil… - International Journal of …, 2022 - mdpi.com
Diabetes-induced vascular disorder is considered one of the deadly risk factors among
diabetic patients that are caused by persistent hyperglycemia that eventually leads to …